Brief: Nymox Announces New Marketing Submission For NYMOZARFEX For BPH
05/12/2022 14:45
Dec 5 (Reuters) - Nymox Pharmaceutical Corp NYMX.O :
* NYMOX ANNOUNCES NEW MARKETING SUBMISSION FOR
NYMOZARFEX™ FOR BPH
* NYMOX PHARMACEUTICAL CORP - ANNOUNCE A NEW FORMAL
SUBMISSION HAS
BEEN MADE IN EUROPE FOR FEXAPOTIDE TRIFLUTATE FOR TREATMENT BPH
* NYMOX PHARMACEUTICAL CORP - MARKETING AUTHORIZATION
APPLICATION
(MAA) WAS SUBMITTED TO DANISH AUTHORITIES
Source text for Eikon: ID:nGNX7g0gmX
Further company coverage: NYMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba